Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Lancet 397 (10286), 17361748
This advanced peptide blend synergistically combines Ipamorelins selective GH secretion, CJC-1295s extended pituitary stimulation, and IGF-LR3s direct anabolic signaling to create a comprehensive, multi-pathway approach to growth hormone optimization and tissue regeneration
Compound Overview This blend combines Tesamorelin and Ipamorelin, two synthetic peptides studied for their interaction with signalling pathways and regulatory systems
Neuropharmacology Cognitive dysfunction and metabolic comorbidities in mood disorders : A repurposing opportunity for glucagon-like peptide 1 receptor agonists
US$ 24.25
US$ 28.11
US$ 26.92
US$ 27.45
US$ 25.89
US$ 25.98
US$ 22.97
US$ 22.11
US$ 24.98
